Literature DB >> 25621416

Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses.

Yong Cui1, Jason D Robinson1, Jeffrey M Engelmann1, Cho Y Lam2, Jennifer A Minnix1, Maher Karam-Hage1, David W Wetter2, John A Dani3, Thomas R Kosten4, Paul M Cinciripini1.   

Abstract

Nicotine dependence has been suggested to be related to reinforcement sensitivity, which encompasses behavioral predispositions either to avoid aversive (behavioral inhibition) or to approach appetitive (behavioral activation) stimuli. Reinforcement sensitivity may shape motives for nicotine use and offer potential targets for personalized smoking cessation therapy. However, little is known regarding how reinforcement sensitivity is related to motivational processes implicated in the maintenance of smoking. Additionally, women and men differ in reinforcement sensitivity, and such difference may cause distinct relationships between reinforcement sensitivity and motivational processes for female and male smokers. In this study, the authors characterized reinforcement sensitivity in relation to affect, smoking-related reinforcement motives, and affective responses, using self-report and psychophysiological measures, in over 200 smokers before treating them. The Behavioral Inhibition/Activation Scales (BIS/BAS; Carver & White, 1994) was used to measure reinforcement sensitivity. In female and male smokers, BIS was similarly associated with negative affect and negative reinforcement of smoking. However, positive affect was positively associated with BAS Drive scores in male smokers, and this association was reversed in female smokers. BIS was positively associated with corrugator electromyographic reactivity toward negative stimuli and left frontal electroencephalogram alpha asymmetry. Female and male smokers showed similar relationships for these physiological measures. These findings suggest that reinforcement sensitivity underpins important motivational processes (e.g., affect), and gender is a moderating factor for these relationships. Future personalized smoking intervention, particularly among more dependent treatment-seeking smokers, may experiment to target individual differences in reinforcement sensitivity. (PsycINFO Database Record (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 25621416      PMCID: PMC4469611          DOI: 10.1037/adb0000050

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  46 in total

1.  Predicting relapse back to smoking: contrasting affective and physical models of dependence.

Authors:  Susan L Kenford; Stevens S Smith; David W Wetter; Douglas E Jorenby; Michael C Fiore; Timothy B Baker
Journal:  J Consult Clin Psychol       Date:  2002-02

2.  Alpha oscillations in response to affective and cigarette-related stimuli in smokers.

Authors:  Yong Cui; Francesco Versace; Jeffrey M Engelmann; Jennifer A Minnix; Jason D Robinson; Cho Y Lam; Maher Karam-Hage; Victoria L Brown; David W Wetter; John A Dani; Thomas R Kosten; Paul M Cinciripini
Journal:  Nicotine Tob Res       Date:  2012-10-11       Impact factor: 4.244

3.  The effects of smoking deprivation and nicotine administration on emotional reactivity.

Authors:  Paul M Cinciripini; Jason D Robinson; Brian L Carter; Cho Lam; XiFeng Wu; Carl A de Moor; Walter F Baile; David W Wetter
Journal:  Nicotine Tob Res       Date:  2006-06       Impact factor: 4.244

4.  Behavioral activation and inhibition in everyday life.

Authors:  S L Gable; H T Reis; A J Elliot
Journal:  J Pers Soc Psychol       Date:  2000-06

5.  Beyond cue reactivity: blunted brain responses to pleasant stimuli predict long-term smoking abstinence.

Authors:  Francesco Versace; Cho Y Lam; Jeffrey M Engelmann; Jason D Robinson; Jennifer A Minnix; Victoria L Brown; Paul M Cinciripini
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

6.  Mood differences between male and female light smokers and nonsmokers.

Authors:  Sandra E File; Abigail K Dinnis; Joy E Heard; Elaine E Irvine
Journal:  Pharmacol Biochem Behav       Date:  2002-06       Impact factor: 3.533

7.  A meta-analysis of emotional reactivity in major depressive disorder.

Authors:  Lauren M Bylsma; Bethany H Morris; Jonathan Rottenberg
Journal:  Clin Psychol Rev       Date:  2007-10-11

8.  The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy.

Authors:  Paul M Cinciripini; David W Wetter; Rachel T Fouladi; Janice A Blalock; Brian L Carter; Lynn G Cinciripini; Walter F Baile
Journal:  J Consult Clin Psychol       Date:  2003-04

Review 9.  Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Authors:  Kate Cahill; Sarah Stevens; Rafael Perera; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

10.  Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

Authors:  Robert West; Christine L Baker; Joseph C Cappelleri; Andrew G Bushmakin
Journal:  Psychopharmacology (Berl)       Date:  2007-12-15       Impact factor: 4.530

View more
  3 in total

1.  The Role of Motivation Systems, Anxiety, and Low Self-Control in Smartphone Addiction among Smartphone-Based Social Networking Service (SNS) Users.

Authors:  Min-Jung Kwak; Hyun Cho; Dai-Jin Kim
Journal:  Int J Environ Res Public Health       Date:  2022-06-05       Impact factor: 4.614

2.  The influence of personality traits on smokers' affect, withdrawal and cessation intervention outcome.

Authors:  Yong Cui; Rui Tang; Cho Y Lam; Paul M Cinciripini; Jason D Robinson
Journal:  Addict Behav       Date:  2015-11-26       Impact factor: 3.913

Review 3.  Trans-diagnostic measurement of impulsivity and compulsivity: A review of self-report tools.

Authors:  Roxanne W Hook; Jon E Grant; Konstantinos Ioannidis; Jeggan Tiego; Murat Yücel; Paul Wilkinson; Samuel R Chamberlain
Journal:  Neurosci Biobehav Rev       Date:  2020-10-25       Impact factor: 8.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.